Robertson Stephen P.
SEC CIK 1837798 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | EVP, GC | 588.8K | — | $2.19M | 16 | 2022-03-02 | 2026-09-10 |
Most active insiders at AUPH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TANG KEVIN | Dir | $25.14M | — |
| 2 | Robertson Stephen P. | EVP, GC | — | $546.4K |
| 3 | Cole Ryan | COO | — | — |
| 4 | Keenan Greg | SVP, Chief Medical Off | — | — |
| 5 | Hearne Michael S | CFO | — | — |
| 6 | Miller Joseph M | CFO | — | — |
| 7 | Donley Matthew Maxwell | COO | — | — |
| 8 | Bailey Jeffrey Allen | Dir | — | — |
| 9 | Johnson Craig A | Dir | — | — |
| 10 | Greenleaf Peter | CEO, Dir | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-11 16:26 | 2026-09-10 | AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | CLO | S - Sale | $15.95 | -11.9K | 588.8K | -2% | -$190.4K | |
| 2026-08-25 21:29 | 2026-08-21 | AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | CLO | S - Sale | $16.97 | -21.0K | 600.8K | -3% | -$355.9K | |
| 2026-05-20 17:05 | 2026-05-18 | AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | CLO | A - Grant | $0.00 | +115.5K | 621.4K | +23% | $0 | |
| D | 2026-03-03 | 2026-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | EVP, GC | F - Tax | $14.21 | -36.5K | 505.9K | -7% | -$519.0K |
| D | 2026-03-03 | 2026-02-27 | AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | EVP, GC | A - Grant | $0.00 | +59.1K | 542.4K | +12% | $0 |
| 2026-02-23 | 2026-02-20 | AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | EVP, GC | F - Tax | $14.40 | -34.6K | 483.3K | -7% | -$498.8K | |
| 2026-01-05 | 2026-01-02 | AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | EVP, GC | A - Grant | $0.00 | +48.6K | 557.4K | +10% | $0 | |
| 2026-01-05 | 2026-01-02 | AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | EVP, GC | F - Tax | $15.95 | -40.4K | 517.9K | -7% | -$644.1K | |
| DM | 2025-03-04 | 2025-03-03+ | AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | EVP, GC | S - Sale | $7.96 | -122.5K | 566.9K | -18% | -$975.2K |
| DM | 2025-03-04 | 2025-02-28+ | AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | EVP, GC | A - Grant | $0.00 | +186.5K | 529.3K | +54% | $0 |
| 2024-03-07 | 2024-03-06 | AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | EVP, GC | S - Sale | $5.60 | -57.7K | 443.8K | -12% | -$323.4K | |
| A | 2024-02-22 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | EVP, GC | S - Sale | $8.78 | -19.6K | 303.1K | -6% | -$172.5K |
| 2024-02-22 | 2024-02-20 | AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | EVP, GC | A - Grant | $0.00 | +194.2K | 501.6K | +63% | $0 | |
| 2023-03-06 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | EVP, GC | A - Grant | — | +204.8K | 322.8K | +174% | — | |
| 2023-03-06 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | EVP, GC | S - Sale | $8.94 | -19.4K | 303.4K | -6% | -$173.5K | |
| D | 2022-03-04 | 2022-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | EVP, GC | A - Grant | $0.00 | +8,500 | 11.7K | +267% | $0 |
Purchase Sale Sale after option exercise All abbreviations